ORBi: Hiligsmann Mickaël - Cost-effectiveness of Denosumab compared with generic alendronate in the treatment of postmenopausal osteoporotic women

Reference : Cost-effectiveness of Denosumab compared with generic alendronate in the treatment of po...


	Document type :	Scientific congresses and symposiums : Paper published in a journal
	Discipline(s) :	Human health sciences : Rheumatology Human health sciences : Public health, health care sciences & services Business & economic sciences : Special economic topics (health, labor, transportation…)
	To cite this reference:	http://hdl.handle.net/2268/88517

Title :	Cost-effectiveness of Denosumab compared with generic alendronate in the treatment of postmenopausal osteoporotic women
Language :	English
Author, co-author :	Hiligsmann, Mickaël [Université de Liège - ULg > Département des sciences de la santé publique & HEC-Ecole de Gestion > > >]
	Reginster, Jean-Yves [Université de Liège - ULg > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
Publication date :	Mar-2011
Journal title :	Osteoporosis International
Publisher :	Springer Science & Business Media B.V.
Volume :	22
Issue/season :	Suppl.1
Pages :	S112-113
On invitation :	No
Audience :	International
ISSN :	0937-941X
e-ISSN :	1433-2965
City :	Godalming
Country :	United Kingdom
Event name :	European Congress on Osteoporosis and Osteoarthritis ECCEO11-IOF
Event date :	du 23 mars 2011 au 26 mars 2011
Event organizer :	International Osteoporosis Foundation and National Osteoporosis Foundation 2011
Event place (city) :	Valencia
Event country :	Spain
Permalink :	http://hdl.handle.net/2268/88517

File(s) associated to this reference

Fulltext file(s):

	File	Commentary	Version	Size	Access
Restricted access	OC36.pdf		Publisher postprint	60.71 kB	Request copy

Additional material(s):

	File	Commentary	Version	Size	Access
Restricted access	OC36.pdf	Communication orale	-	368.19 kB	Request copy

All documents in ORBi are protected by a user license.